Suppr超能文献

性别相关分析在接受直接经皮冠状动脉介入治疗的患者中的短期和长期临床结局和出血的影响:RISK-PCI 数据评估。

Sex-related analysis of short- and long-term clinical outcomes and bleeding among patients treated with primary percutaneous coronary intervention: an evaluation of the RISK-PCI data.

机构信息

School of Medicine, University of Belgrade, Belgrade, Serbia.

出版信息

Can J Cardiol. 2013 Sep;29(9):1097-103. doi: 10.1016/j.cjca.2012.11.013. Epub 2013 Feb 23.

Abstract

BACKGROUND

Unfavourable effect of female sex on short- and long-term clinical outcomes has been demonstrated in unselected ST-elevation acute myocardial infarction (STEMI) patients; the results are conflicting in patients who undergo primary percutaneous coronary intervention (PPCI). The objective of this substudy was to determine whether there are sex-related differences in the 30-day and 1-year clinical outcomes and bleeding after PPCI for STEMI.

METHODS

We analyzed 2096 STEMI patients enrolled in the Risk Scoring Model to Predict Net Adverse Cardiovascular Outcomes After Primary Percutaneous Coronary Intervention (RISK-PCI) trial from February 2006 to December 2009. Composite efficacy end point comprised all-cause mortality, nonfatal infarction, and stroke. Safety end point was bleeding classified according to the Thrombolysis in Myocardial Infarction (TIMI) criteria. Net adverse cardiovascular events included composite efficacy end point and total bleeding.

RESULTS

Women in our study were older and presented later than men. After adjustment for potential confounders, there was no difference between sexes with respect to the composite efficacy end point. A higher rate of total bleeding was observed in women (adjusted odds ratio [OR], 1.67; 95% confidence interval [CI], 1.07-2.61 at 30 days, adjusted OR, 1.63; 95% CI, 1.08-2.47 at 1 year) compared with men. Total bleeding was associated with increased mortality at 30 days (OR, 4.87; 95% CI, 2.79-8.47) and at 1 year (OR, 4.43; 95% CI, 2.79-7.02) after PPCI.

CONCLUSIONS

We did not find a significant sex-related difference with respect to the composite efficacy end point. Women had a higher rate of total bleeding which was associated with increased short- and long-term mortality. Specific measures aimed at preventing bleeding in women might improve the prognosis of PPCI patients.

摘要

背景

在未经选择的 ST 段抬高型急性心肌梗死(STEMI)患者中,女性对短期和长期临床结局的不利影响已得到证实;但在接受直接经皮冠状动脉介入治疗(PPCI)的患者中,结果存在争议。本亚研究的目的是确定在 STEMI 患者接受 PPCI 后 30 天和 1 年的临床结局和出血方面是否存在与性别相关的差异。

方法

我们分析了 2096 名 STEMI 患者,这些患者来自 2006 年 2 月至 2009 年 12 月 RISK-PCI 试验中的风险评分模型预测直接经皮冠状动脉介入治疗后净不良心血管结局。复合疗效终点包括全因死亡率、非致死性梗死和卒中等。安全性终点为根据血栓溶解治疗心肌梗死(TIMI)标准分类的出血。净不良心血管事件包括复合疗效终点和总出血。

结果

在我们的研究中,女性比男性年龄更大,且就诊时间更晚。在调整潜在混杂因素后,两性之间在复合疗效终点方面没有差异。与男性相比,女性总出血发生率更高(调整后的优势比 [OR],30 天时为 1.67;95%置信区间 [CI],1.07-2.61;1 年时为 1.63;95%CI,1.08-2.47)。总出血与 30 天时的死亡率增加相关(OR,4.87;95%CI,2.79-8.47),与 1 年后的死亡率增加相关(OR,4.43;95%CI,2.79-7.02)。

结论

我们没有发现复合疗效终点与性别相关的显著差异。女性总出血发生率较高,与短期和长期死亡率增加相关。针对女性预防出血的具体措施可能会改善 PPCI 患者的预后。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验